Triple negative breast cancer (TNBC) is an aggressive disease that is twice as likely to be diagnosed in African American (AA) women compared to white women, with poor clinical outcomes. Tumor infiltrating lymphocytes (TILs) are associated with improved survival for TNBC, but the relevance of TILs and immune cell subtypes to survival in AA women with TNBC is unknown. We evaluated histopathologic TIL counts and molecular characteristics among 60 AA women diagnosed with TNBC with linkage to clinical outcomes using data from the Metropolitan Detroit Cancer Surveillance System. We utilized whole genome expression profiling of TN tumors and cell type deconvolution analysis to evaluate the underlying mechanisms and immune cell subtypes associated with survival patterns in the context of TILs. 
expression biomarkers of worse survival among African American women with triple negative breast cancer.
INTRODUCTION
Triple negative breast cancer (TNBC), defined by low or no expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor-2 (HER2), is an aggressive disease that is twice as likely to be diagnosed in Black/African
American women compared to white/European American women (1) . Overall clinical outcomes for TNBC are poor yet heterogeneous: peak death and recurrence rates (~30%) occur within the first three years following treatment, but survival rates for the women who live beyond this timeframe are similar to those of hormone receptor positive breast cancers (2) . Poor TNBC survival is a large contributor to the racial disparity in overall breast cancer outcomes since African American women are at higher risk for this subtype, where African American women are 1.4-fold more likely to die from overall breast cancer than European American women (3) .
Several studies further suggest that African American women with TNBC specifically experience poorer clinical outcomes compared to European American women (4) (5) (6) (7) (8) (9) , although this relationship is less clear.
Tumor infiltrating lymphocytes (TILs) are a well-established, favorable prognostic factor for overall breast cancer, including TNBC, that may in part account for the observed heterogeneity in prognosis among women with TNBC (10) (11) (12) . These mononuclear immune cells, representing a heterogeneous population of T cells, B cells, natural killer (NK) cells, and others, infiltrate tumor tissue into either the desmoplastic stroma (stromal TILs, sTILs) and/or into tumor cell clusters (intratumoral TILs, iTILs), and are representative of a patient's immunological response to the tumor (13) . TILs have recently been described as most prevalent in TNBC compared to other breast cancer subtypes, where ~20% of tumors exhibit high levels of TILs (>50% lymphocytic infiltrate), which seems to synergize with chemotherapeutic agents to provide a 30% reduction in risk of death (10) (11) (12) (14) (15) (16) . However, 10-20% of TN tumors are estimated to have no immune infiltrate, representing a subpopulation of TNBC patients that may benefit from strategies to enhance immunity (10) . This would be particularly impactful for African American women with TNBC, for whom there is evidence that TNBC clinical outcomes are worse than European American women (7) (8) (9) . Indeed, there is evidence that substantial racial differences in tumor immunobiology and microenvironment exist and may contribute to racial differences in survival, although this has not been evaluated in TNBC to our knowledge (17) (18) (19) (20) .
Although histopathologic TIL counts provide strong prognostic information, the relative contributions of the underlying cell types represented by this summary measure to survival remain unknown. To date, studies of TILs in TNBC have overwhelmingly focused on the contribution of CD8+ T cells to this response, including CD4+ T helper 1 (TH1) cells that facilitate direct lysing of tumor cells via cytokines and FOXP3+ T regulatory (TREG) cells that dampen CD8+ immune response (10, (21) (22) (23) . However, these approaches capture an incomplete picture of the complex, multifactorial immune response. Two recent studies utilizing publically available expression microarray data examined the association between 22 immune cell subtypes and clinical outcomes in breast cancers using bioinformatic cell type deconvolution (24,25). The one study able to stratify by ER, PR, and HER2 status found that higher fractions of neutrophils, resting mast cells, M2 macrophages, resting NK cells, and resting CD4+ memory T cells were associated with worse overall survival, and better overall survival was associated with higher fractions of plasma and naïve B cells among TNBC (25). However, no racial information was utilized in this analysis, so the relevance of these immune subtypes for African American women is unclear. Here, we evaluate histopathologic TIL counts and molecular characteristics of TNBC lesions among a cohort of African American women. Using gene expression profiles and cell type deconvolution, we describe potential mechanisms and immune cell populations that mediate the association between TILs and survival. A total of 239 eligible women were identified; tumor samples were obtained for sixty of these patients for expression profiling. Clinical, treatment, and outcomes data were obtained via linkage with the SEER registry, including stage, grade, laterality, age at diagnosis, ER/PR/HER2 status, surgery type, systemic therapy type, radiation, sequence of surgery and systemic therapy (among women who had chemotherapy), vital status at last contact, cause of death, and date of last contact. Menopausal status was obtained from medical record review. This study was approved for exemption by Wayne State University Institutional Review Board.
METHODS

Study population and follow-up
Histopathology and gene expression profiling
Slides were cut from formalin-fixed paraffin-embedded (FFPE) blocks and stained with hematoxylin and eosin (H&E) in the Biobanking and Correlative Sciences Core at the Karmanos Cancer Institute. Tissue curls were generated from four 10mm unstained slides corresponding to the tumor area and collected in DNAse/RNAse free microcentrifuge tubes. Total RNA was extracted using the QIASymphony Automated system (Qiagen, Germany) according to the manufacturer protocol. Gene expression profiling was performed using Affymetrix Human Gene ST 2.0 arrays after amplification of RNA using the Affymetrix WT Pico Kit (Santa Clara, CA).
Raw probe intensity data was exported for statistical analysis.
TIL scoring
H&E slides were reviewed by a single breast cancer pathologist (S.B.). TILs were scored using methods outlined by the International TILs Working Groups (26) for both stromal (sTIL) and intratumoral (iTIL) tumor-infiltrating lymphocytes separately. All mononuclear cells, including lymphocytes and plasma cells, and excluding polymorphonuclear leukocytes and granulocytes, inside the boundaries of the invasive tumor were included. sTILs were defined as those within the stroma but not in contact with tumor cells, and were scored as present versus absent. iTILs were scored using the following categories: 0%, 1-10%, 11-50%, >50%.
Bioinformatics
Pathway analyses were conducted using Ingenuity® Pathway Analysis (IPA) software (Qiagen, Hilden, Germany). Enrichment for canonical pathways was evaluated, where we considered pathways with p-values <0.001 and at least five molecules from our gene list were present. Cell type deconvolution was performed as implemented in the CIBERSORT program 
Statistical analysis
Due to the small number of tumors containing >50% iTILs (n=9), we collapsed the variable to categories of 0%, 1-10%, and >10% for all analyses. Chi-squared tests, Fisher's exact tests, and t-tests were used to evaluate associations between iTILs and clinical/pathologic characteristics. Associations between both iTILs (coded 0, 1, 2 corresponding to 0%, 1-10%, >10%) and sTILs (present vs. absent) considered as categorical variables and overall survival were evaluated in Cox proportional hazards (CoxPH) models as implemented in the "survival" package in R (https://cran.r-project.org/), adjusting for stage and age at diagnosis. Subset analyses among women with known chemotherapy sequence (adjuvant vs. neoadjuvant) were performed to evaluate the effect of including treatment type and chemotherapy sequence as covariates in survival models. Raw probe intensity data were normalized as implemented by the "rma" function in R to perform background subtraction, quantile normalization, and summarization of probe sets using median-polish, resulting in 44,629 transcript probes for analysis (27,016 coding, 17,613 non-coding). Given that sTILs were present in more than 85% of tumors and the previously reported associations between iTILs and survival (28-32), we focused all survival and genetic analyses on iTILs. Given that categorical iTIL associations with survival were consistent with a log-linear relationship between iTIL category and survival, subsequent analyses were conducted using iTILs as an ordinal variable. We evaluated associations between iTILs and each of the 44,629 transcripts using linear regression. Transcripts were selected for subsequent analyses using a liberal significance threshold of p<0.01 (n=524), and pathway
analysis was utilized to demonstrate that these associations represented significant enrichment of biologically relevant immune pathways. These transcripts were evaluated as predictors of survival in CoxPH models adjusting for age, stage, and iTIL level. We then formally evaluated these transcripts as causal mediators of the association between iTILs and survival using the "mediation" package in R, which provided effect estimates and p-values for the direct effect of iTILs on survival, the mediation effect of the transcript, and the proportion of the iTIL effect that is mediated by the transcript. This package allowed for parametric modelling, such that we individually fit 1) gene expression predicted by iTIL level via linear regression and 2) the survival model with iTILs, transcript probe, and age and stage at diagnosis as predictors using the "survreg" function. Given that transcripts were evaluated on the basis of a priori evidence of association with iTILs, mediation was considered statistically significant if the mediation and direct effect p-values for the transcript probes were both <0.05. Cell type proportions from CIBERSORT analysis were evaluated dichotomized by their median in CoxPH models adjusting for iTILs, stage, and age at diagnosis for associations with survival. Cell type proportions were also evaluated for correlations with the expression of 34 transcripts of interest in linear regression models.
RESULTS
TNBC cohort
Sixty African American women from metropolitan Detroit with primary invasive triplenegative breast cancer for whom tumor blocks were available comprise our study cohort. A total of 75% of cases were pathologically detected to have intratumoral tumor-infiltrating lymphocytes (iTILs) present and more than 85% had stromal TILs present (Table 1, Figure S1 ).
Mean age at diagnosis was significantly associated with iTILs, where women with any iTILs present were diagnosed with TNBC nearly 10 years younger than women with no iTILs (p=6.7x10 -3 ). Similarly, menopausal status was significantly associated with iTIL levels, where nearly half of women with any iTILs were pre-menopausal compared to less than 10% of women with no iTILs (p=0.038). Among women in our cohort, there were no significant differences in stage at diagnosis and laterality by level of iTILs detected in the tumors ( Table 1) . Among those with known type of surgical therapy, 58.6% of cases underwent surgical mastectomy for primary TNBC treatment. The majority of patients received chemotherapy treatment (>90%), while fewer patients underwent radiation therapy for their breast cancer (>70%). Although chemotherapy data from SEER are incomplete, sub-set analyses among those with known chemotherapy type allowed us to evaluate potential differences in associations for those with neoadjuvant versus adjuvant chemotherapy. There was no association between therapy type or sequence of systemic therapy and surgery and iTILs. ] (Table S1, Figure S2 ). Although systemic therapy and surgery sequence were not associated with TILs, we also evaluated the impact of neoadjuvant chemotherapy (NAC) compared to adjuvant chemotherapy on the association between TILs and survival among women with known chemotherapy type. In a multivariable model, NAC was associated with increased risk of death; however, timing of chemotherapy did not impact the magnitude of association between iTILs and overall or breast cancer specific survival ( Table 2, Table S1 ), regardless of the inclusion of surgery type or radiation treatment. We thus utilized Model 1, with iTILs, age at diagnosis, and stage as predictors, for all subsequent survival analyses.
TILs & TNBC survival
Gene expression patterns associated with TILs & survival
To better understand the molecular and cellular pathways-as represented by expression patterns-captured by histopathologically-defined iTILs in these TN tumors, we next interrogated ontologic pathway enrichment among transcripts associated with iTILs. At p<0.01, a total of 524 transcripts (326 coding, 198 non-coding) were associated with iTILs (Table S2) .
Among these, 224 transcripts were inversely associated with iTILs such that tumors with higher levels of iTILs had lower levels of expression of these transcripts. Of the 198 non-coding transcripts, 78 (36%) were long non-coding (lnc) RNAs, compared to only 26% of all noncoding transcripts on the array that correspond to lncRNAs. We evaluated functional pathway enrichment among the 326 significant coding transcripts using Ingenuity® Pathway Analysis (IPA) software, finding that a wide range of immune cell types and pathways were represented, confirming that the significant transcripts from our analyses likely represent biologically relevant expression patterns. These fell largely into five general categories: (1) antigen presentation, (2) autoimmune signaling involving abnormal B cell recognition of self-antigens, (3) dendritic cell signaling, (4) B and T cell development and differentiation, and (5) T cell activation and signaling (Table S3) .
While these 524 significant transcripts likely reflect the cell types encompassed by histopathologic TIL review, we sought to further refine this list to identify those also relevant to survival in TNBC. Thus, we next examined whether these 524 transcripts were associated with survival when accounting for iTIL levels, age and stage at diagnosis. A total of 34 of these transcripts were significantly associated with survival in this model (p<0.05) ( Table 3) , falling into two categories: (1) twelve transcripts that appeared to attenuate the effect of iTILs on survival and (2) twenty-two transcripts that appeared to enhance the effect of iTILs on survival.
Within this first group of twelve transcripts, the magnitude of iTIL effect attenuation ranged from 5.5-47.4%, and formal mediation analysis indicated that all of these 12 transcripts may partially mediate the relationship between iTILs and survival with at least marginal statistical significance (Table 3) . Interestingly, more than half of these transcripts were more highly expressed in tumors with lower levels of immune infiltrate, including H2AFJ, TRIM64C, and FAM90A1, suggesting that in a subset of TN tumors, iTILs may improve survival by suppressing the cells that highly express these transcripts. Within the second group of twenty-two transcripts, the effect of iTILs on survival strengthened by 13.6-55.6%. Half of these transcripts were more highly expressed in tumors with higher levels of immune infiltrate (e.g., TAP2, PAX6, FAM84B, 
Immune cell subtypes
To tease apart the effects we observed in our agnostic gene expression analysis, we performed a cell type deconvolution analysis using the CIBERSORT program. There was a wide range in the distribution of cell types estimated to be present in these tumors using CIBERSORT. Direction and strength of association between each gene and a) survival and b) iTILs are shown using "+" for positive associations or "−" for inverse associations, such that a "+" survival association indicates that increased expression of the gene is associated with better survival and a "+" iTIL association indicates that increased expression of the gene is associated with higher iTIL levels. Symbol size is proportional to the size of the effect estimate (see Table 3 ). Grey lines separate genes according to patterns of association with survival and iTILs. Triangles are shaded and oriented according to the direction of association between the cell type proportion and the gene of interest: downward blue=inverse association, upward red=positive association.
Color intensity is proportional to statistical significance. Triangle size is proportional to log10 of the absolute value of the regression coefficient. * Association between TIL score (ordinal) and probe expression ** Survival predicted by iTILs, probe expression, stage, and age at diagnosis † Degree to which the iTIL effect on survival is attenuated in Survival Model 2 compared to survival predicted by iTILs, stage, and age at diagnosis (iTIL HR=0.41, 95% CI 0.21-0.81)NONHSAT074584  XR_428030  RNU7−27P  ENST00000364639  NCF1B  XLOC_l2_005116  H2AFJ  ENST00000364796  TRIM64C  FAM90A1  XLOC_l2_005602  ENST00000531742  MIR3130−1  IL15RA  OTTHUMT00000338373  OTTHUMT00000338373  n379368  IGKV4−1  IGLV3−27  IGK  IGK  IGHA1  YME1L1  LOC100130502  FAM84B  ENST00000362431  PHC1  GOLGA8S  ENST00000517111  PRSS50  ENST00000510602  SRGAP2  PAX6 
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